HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $104,706 | +1208.8% | 37,800 | +3189.8% | 0.00% | – |
Q1 2021 | $8,000 | -68.0% | 1,149 | -80.8% | 0.00% | – |
Q4 2020 | $25,000 | +316.7% | 5,988 | +236.6% | 0.00% | – |
Q3 2020 | $6,000 | -45.5% | 1,779 | -41.9% | 0.00% | – |
Q2 2020 | $11,000 | – | 3,061 | +5786.5% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 52 | -99.8% | 0.00% | – |
Q1 2019 | $96,000 | +33.3% | 22,163 | -2.3% | 0.00% | – |
Q4 2018 | $72,000 | -38.5% | 22,678 | +1.2% | 0.00% | – |
Q3 2018 | $117,000 | -1.7% | 22,409 | -0.0% | 0.00% | – |
Q2 2018 | $119,000 | +8.2% | 22,412 | +1.1% | 0.00% | – |
Q1 2018 | $110,000 | -89.7% | 22,162 | -92.1% | 0.00% | -100.0% |
Q3 2015 | $1,065,000 | -71.8% | 281,878 | -57.4% | 0.00% | -75.0% |
Q2 2015 | $3,771,000 | -9.0% | 661,513 | -7.1% | 0.00% | -20.0% |
Q1 2015 | $4,144,000 | -28.1% | 711,988 | -30.0% | 0.01% | -28.6% |
Q4 2014 | $5,764,000 | +40.7% | 1,016,628 | +1.5% | 0.01% | +40.0% |
Q3 2014 | $4,097,000 | +9.0% | 1,001,830 | +21.3% | 0.01% | +25.0% |
Q2 2014 | $3,757,000 | – | 825,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |